Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model
出版年份 2016 全文链接
标题
Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model
作者
关键词
-
出版物
GENE THERAPY
Volume 23, Issue 12, Pages 829-838
出版商
Springer Nature
发表日期
2016-08-02
DOI
10.1038/gt.2016.60
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hyaluronic acid for anticancer drug and nucleic acid delivery
- (2016) Franco Dosio et al. ADVANCED DRUG DELIVERY REVIEWS
- Structure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectors
- (2016) Vivek D. Badwaik et al. BIOMATERIALS
- Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
- (2016) Manju Kanamala et al. BIOMATERIALS
- Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging
- (2016) Jae-Young Lee et al. BIOMATERIALS
- A novel type of self-assembled nanoparticles as targeted gene carriers: an application for plasmid DNA and antimicroRNA oligonucleotide delivery
- (2016) Yanliang Zhu et al. International Journal of Nanomedicine
- Facile Construction of pH- and Redox-Responsive Micelles from a Biodegradable Poly(β-hydroxyl amine) for Drug Delivery
- (2015) Dawei Li et al. BIOMACROMOLECULES
- A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation
- (2015) Gang Xue et al. CANCER LETTERS
- MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1
- (2015) Guohui Wang et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart
- (2015) M Merentie et al. GENE THERAPY
- TGF-β1-siRNA delivery with nanoparticles inhibits peritoneal fibrosis
- (2015) H Yoshizawa et al. GENE THERAPY
- Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer
- (2015) J Niu et al. ONCOGENE
- miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR
- (2015) Wenhua Li et al. Oncotarget
- Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma
- (2015) Sippy Kaur et al. Clinical Epigenetics
- miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
- (2015) Ruifen Dong et al. Oncotarget
- A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
- (2014) A L Kasinski et al. ONCOGENE
- Biodegradable self-assembled nanoparticles of poly (d,l-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer
- (2013) Jingbin Huang et al. BIOMATERIALS
- miRNA Dysregulation in Breast Cancer
- (2013) L. Mulrane et al. CANCER RESEARCH
- miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer
- (2013) C.-C. Yu et al. CANCER RESEARCH
- Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPLS447X) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene Therapy
- (2013) Valerie Ferreira et al. HUMAN GENE THERAPY
- Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
- (2013) Wenjia Lou et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity
- (2012) Ahmed A. Eltoukhy et al. BIOMATERIALS
- HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
- (2012) N. Duru et al. CLINICAL CANCER RESEARCH
- Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma
- (2012) Heejeong Lee et al. MODERN PATHOLOGY
- Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression
- (2012) A Pagliuca et al. ONCOGENE
- Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
- (2012) Amanda Tivnan et al. PLoS One
- Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization
- (2012) Armando Stano et al. VACCINE
- Target-Specific Gene Silencing of Layer-by-Layer Assembled Gold–Cysteamine/siRNA/PEI/HA Nanocomplex
- (2011) Min-Young Lee et al. ACS Nano
- A single-monomer derived linear-like PEI-co-PEG for siRNA delivery and silencing
- (2011) Lin-Ren Tsai et al. BIOMATERIALS
- MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
- (2011) A. F. Ibrahim et al. CANCER RESEARCH
- Immune Responses to AAV in Clinical Trials
- (2011) Federico Mingozzi et al. CURRENT GENE THERAPY
- PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells
- (2011) Gao Liang et al. Nanoscale Research Letters
- Amphoteric hyaluronic acid derivative for targeting gene delivery
- (2010) Jing Yao et al. BIOMATERIALS
- Surface functionalisation of PLGA nanoparticles for gene silencing
- (2010) Morten Ø. Andersen et al. BIOMATERIALS
- Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine–hyaluronic acid conjugate
- (2010) Kitae Park et al. BIOMATERIALS
- Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives
- (2009) Eun Ju Oh et al. JOURNAL OF CONTROLLED RELEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started